Development and Validation of Nomograms for Predicting the Prognosis of Triple-Negative Breast Cancer Patients Based on 379 Chinese Patients

Cancer Management and Research - New Zealand
doi 10.2147/cmar.s234926
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Informa UK Limited

Related search

Development and Validation of Nomograms Predicting Survival in Chinese Patients With Triple Negative Breast Cancer

BMC Cancer
Cancer ResearchOncologyGenetics
2019English

Development and Validation of Nomograms for Predicting Survival in Patients With Non-Metastatic Colorectal Cancer

Oncotarget
Oncology
2017English

Identification of Prognosis-Relevant Subgroups in Patients With Chemoresistant Triple-Negative Breast Cancer

Clinical Cancer Research
Cancer ResearchOncology
2013English

MiRNAs Predict the Prognosis of Patients With Triple Negative Breast Cancer: A Meta-Analysis

PLoS ONE
Multidisciplinary
2017English

Accumulation of P62 Is Associated With Poor Prognosis in Patients With Triple-Negative Breast Cancer

OncoTargets and Therapy
OncologyPharmacology
2013English

Establishment and Validation of Circulating Tumor Cell-Based Prognostic Nomograms in First-Line Metastatic Breast Cancer Patients

Clinical Cancer Research
Cancer ResearchOncology
2013English

Expression of Dickkopf-1 and Beta-Catenin Related to the Prognosis of Breast Cancer Patients With Triple Negative Phenotype

PLoS ONE
Multidisciplinary
2012English

Triple-Negative Breast Cancer Types Exhibit a Distinct Poor Clinical Characteristic in Lymph Node-Negative Chinese Patients

Oncology Reports
MedicineCancer ResearchOncology
1994English

Correction: Expression of Dickkopf-1 and Beta-Catenin Related to the Prognosis of Breast Cancer Patients With Triple Negative Phenotype

PLoS ONE
Multidisciplinary
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy